Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPRC | P08575 | 2/20 | 0.40 |
| ▸ | POLB | P06746 | 5/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | TTR | P02766 | 3/20 | 0.37 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.34 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 2/20 | 0.34 |
| ▸ | CSNK2A2 | P19784 | 1/20 | 0.33 |
| ▸ | CSNK2B | P67870 | 1/20 | 0.33 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.33 |
| ▸ | CSNK2A3 | Q8NEV1 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | TDP2 | O95551 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 3/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11937040 | 0.74 | POLB (0.57) | PTPRCPOLBSMN1; SMN2KMT2ATTR | |
| SCHEMBL4096667 | 0.73 | ALOX5 (0.37) | PTPRCPOLBSMN1; SMN2KMT2AHTT | |
| SCHEMBL31686219 | 0.63 | PTPRC (0.84) | PTPRCPOLBKMT2ATTRTDP1 | |
| SCHEMBL13931149 | 0.61 | HTT (0.55) | PTPRCPOLBSMN1; SMN2KMT2ATTR | |
| SCHEMBL69805 | 0.60 | PTPRC (0.72) | PTPRCPOLBKMT2ATTRTDP1 | |
| SCHEMBL68062 | 0.60 | PTPRC (0.72) | PTPRCPOLBKMT2ATTRTDP1 | |
| SCHEMBL11937039 | 0.60 | TTR (0.52) | PTPRCPOLBSMN1; SMN2KMT2ATTR | |
| SCHEMBL11983054 | 0.60 | TTR (0.47) | PTPRCPOLBSMN1; SMN2KMT2ATTR | |
| SCHEMBL12106079 | 0.59 | TSHR (0.50) | POLBSMN1; SMN2HTTTDP1L3MBTL1 | |
| SCHEMBL68522 | 0.59 | TSHR (0.50) | POLBSMN1; SMN2HTTTDP1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2199273-B1 | Polymerizable photoinitiators and radiation curable compositions | AGFA NV (BE) | 2018-02-21 | — | — | EP | disclosed |
| US-8492452-B2 | Polymerizable photoinitiators and radiation curable compositions | AGFA GRAPHICS NV (BE) | 2013-07-23 | — | — | US | disclosed |
| US-8492452-B2 | Polymerizable photoinitiators and radiation curable compositions | AGFA GRAPHICS NV (BE) | 2013-07-23 | — | — | US | disclosed |
| US-20110224324-A1 | POLYMERIZABLE PHOTOINITIATORS AND RADIATION CURABLE COMPOSITIONS | AGFA GRAPHICS NV (BE) | 2011-09-15 | — | — | US | disclosed |
| US-20110224324-A1 | POLYMERIZABLE PHOTOINITIATORS AND RADIATION CURABLE COMPOSITIONS | AGFA GRAPHICS NV (BE) | 2011-09-15 | — | — | US | disclosed |
| EP-2199273-A1 | Polymerizable photoinitiators and radiation curable compositions | AGFA Graphics NV (BE) | 2010-06-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110224324-A1 | POLYMERIZABLE PHOTOINITIATORS AND RADIATION CURABLE COMPOSITIONS | WEE1, ZYX, MTR | PTPRC 3742/4885POLB 1031/4885SMN1; SMN2 4359/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.